相关实验视频

Updated: Jul 18, 2025

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Published on: August 1, 2018

提亚化物产药和衍生:合成和活性

Andrew V Stachulski¹, Jean-Francois Rossignol², Sophie Pate¹

¹Donnan and Robert Robinson Laboratories, Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K.

ACS bio & med chem Au

|August 21, 2023

概括

氨基酸原剂的 thiazolides 降解为稳定的抗病毒. 这些新型呈现出增强的溶解性和减少的清除,提供了比母类提亚化物更好的药物动力学特性.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
有机化学有机化学

背景情况:

提亚化物前药物是为了增强药物输送和药物动力学特征而开发的.
氨基酸甲酸的氨基酸原药在pH值超过5.5时显示不稳定.
不稳定性归因于水解和一种新的重排路径.

研究的目的:

为了研究氨基酸 thiazolide 前药的降解产品.
描述由此产生的降解产品的特性和生物活性.
评估这些降解产品作为新型治疗剂的潜力.

主要方法:

氨基酸 thiazolide 前药物的合成和表征.
在各种pH条件下进行稳定性研究.
使用光谱方法对降解产品进行隔离和结构阐明.
对分离的的抗病毒活性和药理学参数 (可溶性,清除) 的评估.

主要成果:

氨基酸乙 thiazolide 前药在pH>5时不稳定,通过重新排列产生.
由此产生的是具有显著抗病毒活性的稳定固体.
这些体表现出改善的药物动力学特征,包括增强的溶解度和减少的清除,相比于母类提亚化物.

结论:

提亚化原药的重新排列产生了具有治疗潜力的新型衍生物.
这些代表了一类有前途的化合物,具有改善的类似药物的特性.
这些衍生物的进一步开发可能会导致新的抗病毒疗法.

更多相关视频

Synthesis and Characterization of 1,2-Dithiolane Modified Self-Assembling Peptides

Synthesis and Characterization of 1,2-Dithiolane Modified Self-Assembling Peptides

Published on: August 20, 2018

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

相关概念视频

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...